Target intelligence / Profile preview

Cell populations

Molecular classification
Other
01

Overview

Cell populations refer to heterogeneous or homogeneous groups of cells characterized by shared phenotypic, functional, or genetic traits, such as T-lymphocytes, hematopoietic stem cells, or hepatocytes (National Cancer Institute, 2024). In the context of drug discovery and pharmacology, the term is considered a high-level biological classification rather than a discrete molecular target. While therapies are often described as targeting specific cell populations (e.g., B-cell depletion therapy), the actual therapeutic target is typically a specific receptor, enzyme, or signaling protein expressed by those cells, such as CD20 or BCR-ABL (Nature Reviews Drug Discovery, 2021). Because the term encompasses a vast array of diverse biological entities and lacks a specific molecular structure, it is classified as an incorrect target designation for structured pharmacological data. Understanding the dynamics of cell populations is crucial for precision medicine, as it allows for the identification of cellular drivers of disease and the monitoring of therapeutic efficacy through technologies like flow cytometry and single-cell RNA sequencing (NIH, 2023).

Other names
Cell typesCellular subsetsCell lineagesCellular compartments
02

Mechanism of action

Not applicable; this term refers to a broad biological grouping rather than a specific molecular entity or therapeutic target.

03

Biological functions

Cellular homeostasisImmune surveillanceTissue regenerationSignal integration
04

Disease associations

CancerAutoimmune disordersInfectious diseasesDegenerative diseases
05

Safety considerations

Off-target depletion of essential healthy cell typesSystemic toxicity from broad cellular modulationCytokine release syndrome (CRS) from massive cellular activation
06

Biomarkers

Cluster of differentiation (CD) markersLineage-specific transcription factorsCell-specific gene expression signatures

Beyond the preview

Go deeper on Cell populations.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell populations.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call